Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Inflammation helps stem cells repair tissue by directing their behavior.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

JAK inhibitors show promise in treating difficult skin diseases.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Nanotechnology can improve tissue healing by controlling immune responses.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

JAK inhibitors are effective treatments for alopecia areata.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

JAK inhibitors might help treat alopecia areata.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Upadacitinib improved multiple immune-related conditions in one patient.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.